Picture of Agenus logo

AGEN Agenus Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapValue Trap

Annual cashflow statement for Agenus, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-28.7-231-257-232-3.08
Depreciation
Non-Cash Items41.824.38.8928-111
Unusual Items
Other Non-Cash Items
Changes in Working Capital-9.7424.110.832.627.3
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Cash from Operating Activities10.1-175-224-158-77.2
Capital Expenditures-33.8-53.1-9.95-0.576-0.006
Purchase of Fixed Assets
Other Investing Cash Flow Items-9.3419.513.40.6031.2
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-43.1-33.63.40.0271.19
Financing Cash Flow Items-1.540079.7-1.97
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities22595.812012336.6
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash192-113-102-35.7-39.4